Australis Capital Invests $3 Million in CBD Extraction Company
Australis Capital Invests in Folium Biosciences a Global Leader in Non-Psychoactive Cannabinoid Production LAS VEGAS, Jan. 14, 2019 /PRNewswire/ – Australis Capital Inc. (CSE: AUSA) (“Australis” or the “Company”) is pleased...